Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
May 10, 2024 16:05 ET
|
Ocugen
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Longeveron Announces Board of Directors Planned Transitions
May 10, 2024 16:05 ET
|
Longeveron
Longeveron announces planned transitions on its Board of Directors.
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
May 10, 2024 16:05 ET
|
Acri Capital Acquisition Corporation
Austin, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in order to extend...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024 16:05 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
May 10, 2024 16:05 ET
|
byNordic Acquisition Corp
New York, NY, May 10, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (NASDAQ: BYNO (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company has...
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
May 10, 2024 16:02 ET
|
Cassava Sciences, Inc.
$126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.Over 735 Patients Have Completed a Phase 3...
The Herzfeld Caribbean Basin Fund, Inc. Pays Quarterly Distribution
May 10, 2024 16:01 ET
|
Herzfeld Caribbean Basin Fund
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- The Herzfeld Caribbean Basin Fund, Inc. (NASDAQ: CUBA) (the “Fund”) today announced that the Fund has made the following distribution pursuant to...
CarGurus to Present at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference
May 10, 2024 16:01 ET
|
CarGurus, Inc.
CAMBRIDGE, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 10, 2024 16:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new employees 62,300 restricted stock units (RSUs) under...